tiprankstipranks
Biolase sees FY24 revenue $52M-$53M, consensus $53.01M
PremiumThe FlyBiolase sees FY24 revenue $52M-$53M, consensus $53.01M
3M ago
Biolase reduces workforce by 15%
PremiumThe Fly
Biolase reduces workforce by 15%
3M ago
Biolase sees FY23 revenue $48.9M-$49.2M, consensus $49.21M
PremiumThe Fly
Biolase sees FY23 revenue $48.9M-$49.2M, consensus $49.21M
3M ago
Biolase price target lowered to $3.00 from $5.00 at Maxim
PremiumThe FlyBiolase price target lowered to $3.00 from $5.00 at Maxim
5M ago
Biolase sees FY23 revenue growth 1%-3%, consensus $55.93M
PremiumThe Fly
Biolase sees FY23 revenue growth 1%-3%, consensus $55.93M
6M ago
Biolase reports Q3 adjusted EPS ($2.87), consensus ($1.85)
PremiumThe Fly
Biolase reports Q3 adjusted EPS ($2.87), consensus ($1.85)
6M ago
Biolase reports Q2 EPS ($8.93), consensus ($5.33)
PremiumThe FlyBiolase reports Q2 EPS ($8.93), consensus ($5.33)
9M ago
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
PremiumPress Releases
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
9M ago
BioLase trading resumes
PremiumThe Fly
BioLase trading resumes
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100